Identification of a miR-146b-Fas ligand axis in the development of neutropenia in T large granular lymphocyte leukemia
Barbara Mariotti,
Giulia Calabretto,
Marzia Rossato,
Antonella Teramo,
Monica Castellucci,
Gregorio Barilà,
Matteo Leoncin,
Cristina Vicenzetto,
Monica Facco,
Gianpietro Semenzato,
Flavia Bazzoni,
Renato Zambello
Affiliations
Barbara Mariotti
Department of Medicine, Division of General Pathology, University of Verona, Verona
Giulia Calabretto
Department of Medicine, Hematology and Clinical Immunology section, University of Padua, Padua;Venetian Institute of Molecular Medicine (VIMM), Padua, Italy
Marzia Rossato
Department of Medicine, Division of General Pathology, University of Verona, Verona
Antonella Teramo
Department of Medicine, Hematology and Clinical Immunology section, University of Padua, Padua;Venetian Institute of Molecular Medicine (VIMM), Padua, Italy
Monica Castellucci
Department of Medicine, Division of General Pathology, University of Verona, Verona
Gregorio Barilà
Department of Medicine, Hematology and Clinical Immunology section, University of Padua, Padua;Venetian Institute of Molecular Medicine (VIMM), Padua, Italy
Matteo Leoncin
Department of Medicine, Hematology and Clinical Immunology section, University of Padua, Padua;Venetian Institute of Molecular Medicine (VIMM), Padua, Italy
Cristina Vicenzetto
Department of Medicine, Hematology and Clinical Immunology section, University of Padua, Padua;Venetian Institute of Molecular Medicine (VIMM), Padua, Italy
Monica Facco
Department of Medicine, Hematology and Clinical Immunology section, University of Padua, Padua;Venetian Institute of Molecular Medicine (VIMM), Padua, Italy
Gianpietro Semenzato
Department of Medicine, Hematology and Clinical Immunology section, University of Padua, Padua;Venetian Institute of Molecular Medicine (VIMM), Padua, Italy
Flavia Bazzoni
Department of Medicine, Division of General Pathology, University of Verona, Verona
Renato Zambello
Department of Medicine, Hematology and Clinical Immunology section, University of Padua, Padua;Venetian Institute of Molecular Medicine (VIMM), Padua, Italy
Tlarge granular lymphocyte leukemia (T-LGLL) is characterized by the expansion of several large granular lymphocyte clones, among which a subset of large granular lymphocytes showing constitutively activated STAT3, a specific CD8+/CD4− phenotype and the presence of neutropenia has been identified. Although STAT3 is an inducer of transcription of a large number of oncogenes, so far its relationship with miRNAs has not been evaluated in T-LGLL patients. Here, we investigated whether STAT3 could carry out its pathogenetic role in T-LGLL through an altered expression of miRNAs. The expression level of 756 mature miRNA was assessed on purified T large granular lymphocytes (T-LGLs) by using a TaqMan Human microRNA Array. Hierarchical Clustering Analysis of miRNA array data shows that the global miRNome clusters with CD8 T-LGLs. Remarkably, CD8 T-LGLs exhibit a selective and STAT3-dependent repression of miR-146b expression, that significantly correlated with the absolute neutrophil counts and inversely correlated with the expression of Fas ligand (FasL), that is regarded as the most relevant factor in the pathogenesis of neutropenia. Experimental evidence demonstrates that the STAT3-dependent reduction of miR-146b expression in CD8 T-LGLs occurs as a consequence of miR-146b promoter hypermethylation and results in the disruption of the HuR-mediated post-transcriptional machinery controlling FasL mRNA stabilization. Restoring miR-146b expression in CD8 T-LGLs lead to a reduction of HuR protein and, in turn, of FasL mRNA expression, thus providing mechanistic insights for the existence of a STAT3-miR146b-FasL axis and neutropenia in T-LGLL.